Published in AIDS on September 01, 1996
Challenges associated with increased survival among parents living with HIV. Am J Public Health (2001) 1.25
Anthropometric indices as predictors of survival in AIDS adults. Aquitaine Cohort, France, 1985-1997. Groupe d'Epidémiologie Clinique du Sida en Aquitaine (GECSA). Eur J Epidemiol (2000) 1.04
Survival by AIDS defining condition in rural Uganda. Sex Transm Infect (2000) 1.02
The socioeconomic impact of human immunodeficiency virus / acquired immune deficiency syndrome in India and its relevance to eye care. Indian J Ophthalmol (2008) 0.94
Can we predict the prognosis of HIV infection? How to use the findings of a prospective study. Sex Transm Infect (1998) 0.92
Nutritional status and survival in HIV-1 disease. AIDS (1997) 0.83
Survival of AIDS patients in an academic unit in Athens, Greece. AIDS (1997) 0.75
Human Immunodeficiency Virus (HIV). Transfus Med Hemother (2016) 0.75
Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet (2003) 7.94
Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. Lancet (1998) 7.53
Meta-analysis: principles and procedures. BMJ (1997) 6.87
Data on the distribution of fibre types in thirty-six human muscles. An autopsy study. J Neurol Sci (1973) 6.62
Risk factors for ischaemic heart disease: the prospective phase of the British Regional Heart Study. J Epidemiol Community Health (1985) 5.53
A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nat Genet (2001) 5.34
The implications of using an inappropriate reference gene for real-time reverse transcription PCR data normalization. Anal Biochem (2005) 4.94
Confounding in epidemiological studies: why "independent" effects may not be all they seem. BMJ (1992) 4.79
Social class differences in ischaemic heart disease in British men. Lancet (1987) 4.09
Vigabatrin-associated retinal cone system dysfunction: electroretinogram and ophthalmologic findings. Neurology (1998) 4.01
Smoking as "independent" risk factor for suicide: illustration of an artifact from observational epidemiology? Lancet (1992) 3.92
Very mild muscular dystrophy associated with the deletion of 46% of dystrophin. Nature (1990) 3.84
Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection. Thorax (2004) 3.77
Identifying men at high risk of heart attacks: strategy for use in general practice. Br Med J (Clin Res Ed) (1986) 3.76
The polymerase chain reaction: a new epidemiological tool for investigating cervical human papillomavirus infection. BMJ (1989) 3.43
Growth, survival, and resistance of the Legionnaires' disease bacterium. Ann Intern Med (1979) 3.36
S-nitrosothiols signal the ventilatory response to hypoxia. Nature (2001) 3.26
Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies. Lancet (2003) 3.23
Open access clinic providing HIV-I antibody results on day of testing: the first twelve months. BMJ (1991) 3.17
Staging system for clinical AIDS patients. Royal Free/Chelsea and Westminster Hospitals Collaborative Group. Lancet (1995) 2.90
Passive smoking and health: should we believe Philip Morris's "experts"? BMJ (1996) 2.76
Late presentation of HIV infection: a consensus definition. HIV Med (2011) 2.67
A scoring system to identify men at high risk of a heart attack. Health Trends (1987) 2.58
Comparison of long-term prognosis of patients with AIDS treated and not treated with zidovudine. AIDS in Europe Study Group. JAMA (1994) 2.56
Secondary mutations in the protease region of human immunodeficiency virus and virologic failure in drug-naive patients treated with protease inhibitor-based therapy. J Infect Dis (2001) 2.50
Predictors of virological success and ensuing failure in HIV-positive patients starting highly active antiretroviral therapy in Europe: results from the EuroSIDA study. Arch Intern Med (2000) 2.49
Concentrations of high density lipoprotein cholesterol, triglycerides, and total cholesterol in ischaemic heart disease. BMJ (1989) 2.47
A single amino acid substitution in the V1 loop of human immunodeficiency virus type 1 gp120 alters cellular tropism. J Virol (1993) 2.46
Risk factors for stroke in middle aged British men. BMJ (1991) 2.44
Theophylline prescribing, serum concentrations, and toxicity. Lancet (1983) 2.40
The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D:A:D Study. HIV Med (2006) 2.38
Incidence and consequences of pregnancy in women with known duration of HIV infection. Italian Seroconversion Study Group. Arch Intern Med (1998) 2.38
Laboratory control values for CD4 and CD8 T lymphocytes. Implications for HIV-1 diagnosis. Clin Exp Immunol (1992) 2.27
Diagnosed and undiagnosed HIV-infected populations in Europe. HIV Med (2008) 2.26
Inflation in epidemiology: "the proof and measurement of association between two things" revisited. BMJ (1996) 2.24
The epidemiology of pathogenic mitochondrial DNA mutations. Ann Neurol (2000) 2.20
Influence of age on CD4 cell recovery in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy: evidence from the EuroSIDA study. J Infect Dis (2001) 2.19
Loss of mucosal CD4 lymphocytes is an early feature of HIV infection. Clin Exp Immunol (1993) 2.17
AIDS across Europe, 1994-98: the EuroSIDA study. Lancet (2000) 2.13
Virological response to highly active antiretroviral therapy is unaffected by antituberculosis therapy. J Infect Dis (2006) 2.09
Role of mitochondrial DNA mutations in human aging: implications for the central nervous system and muscle. Ann Neurol (1998) 2.08
Infertility among human immunodeficiency virus-positive women: incidence and treatment dilemmas. Hum Reprod (1996) 2.01
Epidemiology of cerebral palsy in England and Scotland, 1984-9. Arch Dis Child Fetal Neonatal Ed (1998) 2.01
Cardio- and cerebrovascular events in HIV-infected persons. AIDS (2004) 1.98
Survival of AIDS patients according to type of AIDS-defining event. The AIDS in Europe Study Group. Int J Epidemiol (1997) 1.97
Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection. EuroSIDA Study Group. Lancet (1999) 1.95
Migration and geographic variations in ischaemic heart disease in Great Britain. Lancet (1989) 1.95
Lymphocyte activation in HIV-1 infection. II. Functional defects of CD28- T cells. AIDS (1994) 1.93
Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapy. AIDS (2001) 1.92
The association between hepatitis C virus genotype and human immunodeficiency virus disease progression in a cohort of hemophilic men. J Infect Dis (1997) 1.90
Methods of microphotometric assay of succinate dehydrogenase and cytochrome c oxidase activities for use on human skeletal muscle. Histochem J (1990) 1.89
Reasons for modification and discontinuation of antiretrovirals: results from a single treatment centre. AIDS (2001) 1.86
Reference ranges and sources of variability of CD4 counts in HIV-seronegative women and men. Genitourin Med (1996) 1.82
Tenofovir-associated renal and bone toxicity. HIV Med (2009) 1.82
HHV-6 in AIDS. Lancet (1994) 1.76
ABO blood group and ischaemic heart disease in British men. BMJ (1990) 1.76
High density lipoprotein cholesterol is not a major risk factor for ischaemic heart disease in British men. Br Med J (Clin Res Ed) (1986) 1.73
Infrared signature of structures associated with the H+(H2O)n (n = 6 to 27) clusters. Science (2004) 1.71
Dysferlin is a plasma membrane protein and is expressed early in human development. Hum Mol Genet (1999) 1.69
Cytomegalovirus (CMV) viraemia detected by polymerase chain reaction identifies a group of HIV-positive patients at high risk of CMV disease. AIDS (1997) 1.68
Biochemistry of Oleoresinosis : Monoterpene and Diterpene Biosynthesis in Lodgepole Pine Saplings Infected with Ceratocystis clavigera or Treated with Carbohydrate Elicitors. Plant Physiol (1987) 1.68
A new mtDNA mutation showing accumulation with time and restriction to skeletal muscle. Am J Hum Genet (1997) 1.68
Pharmacokinetics and antiretroviral activity of lamivudine alone or when coadministered with zidovudine in human immunodeficiency virus type 1-infected pregnant women and their offspring. J Infect Dis (1998) 1.67
Are there gender differences in starting protease inhibitors, HAART, and disease progression despite equal access to care? J Acquir Immune Defic Syndr (2000) 1.67
Further observations on the pathological responses of rat skeletal muscle to toxins isolated from the venom of the Australian tiger snake, Notechis scutatus scutatus. Clin Exp Pharmacol Physiol (1979) 1.66
Rapid decline in detectability of HIV-1 drug resistance mutations after stopping therapy. AIDS (1999) 1.65
Increased numbers of primed activated CD8+CD38+CD45RO+ T cells predict the decline of CD4+ T cells in HIV-1-infected patients. AIDS (1996) 1.64
Disintegration/dissolution profiles of copies of Fosamax (alendronate). Curr Med Res Opin (2003) 1.62
Do women with HIV infection consult with their GPs? Br J Gen Pract (1998) 1.62
Branhamella (Neisseria) catarrhalis--a lower respiratory tract pathogen? J Clin Microbiol (1981) 1.61
Adverse events and treatment interruption in tuberculosis patients with and without HIV co-infection. Thorax (2006) 1.60
Access to medical care one year prior to diagnosis in 100 HIV-positive women. Fam Pract (1997) 1.59
Relationship between herpes simplex virus ulceration and CD4+ cell counts in patients with HIV infection. AIDS (1992) 1.56
Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study. Lancet (2001) 1.55
Infections with Mycobacterium tuberculosis and Mycobacterium avium among HIV-infected patients after the introduction of highly active antiretroviral therapy. EuroSIDA Study Group JD. Am J Respir Crit Care Med (2000) 1.55
Assessing the cost-effectiveness of HAART for adults with HIV in England. HIV Med (2001) 1.55
Predictors of a viral response and subsequent virological treatment failure in patients with HIV starting a protease inhibitor. AIDS (1998) 1.54
Biosynthesis of monoterpenes: partial purification, characterization, and mechanism of action of 1,8-cineole synthase. Arch Biochem Biophys (1994) 1.53
Data on fibre size in thirty-six human muscles. An autopsy study. J Neurol Sci (1973) 1.53
Heterogeneity of dystrophin expression in patients with Duchenne and Becker muscular dystrophy. Acta Neuropathol (1990) 1.52
Alcohol and ischaemic heart disease in middle aged British men. Br Med J (Clin Res Ed) (1987) 1.51
Factors associated with the development of Pneumocystis carinii pneumonia in 5,025 European patients with AIDS. AIDS in Europe Study Group. Clin Infect Dis (1995) 1.51
Early diagnosis of HIV infection. Br J Hosp Med (1990) 1.51
Age-related hearing loss, vitamin B-12, and folate in elderly women. Am J Clin Nutr (1999) 1.49
Dystrophin in skeletal muscle. II. Immunoreactivity in patients with Xp21 muscular dystrophy. J Neurol Sci (1989) 1.48
Meta-analysis. Beyond the grand mean? BMJ (1997) 1.48
Follow up studies: design, organisation, and analysis. Arch Dis Child (1989) 1.47
The incubation period of AIDS. AIDS (1997) 1.47
Mitochondrial enzyme activity in amyotrophic lateral sclerosis: implications for the role of mitochondria in neuronal cell death. Ann Neurol (1999) 1.46
Human immunodeficiency virus type 1-related pulmonary Mycobacterium xenopi infection: a need to treat? Clin Infect Dis (2003) 1.44